关注并星标CPHI制药在线今年8月底,丹麦制药巨头诺和诺德(Novo Nordisk)宣布与Replicate Bioscience(Replicate)达成一项合作协议,双方将整合诺和诺德在心脏代谢疾病领域的治疗经验和药物开发实力,基于Replicate的自复制RNA(srRNA)平台,共同开发针对肥胖、2型糖尿病等代谢疾病的新型候选疗法。根据协议,Replicate 将有资格从诺和诺德获得高达...
Source Link关注并星标CPHI制药在线今年8月底,丹麦制药巨头诺和诺德(Novo Nordisk)宣布与Replicate Bioscience(Replicate)达成一项合作协议,双方将整合诺和诺德在心脏代谢疾病领域的治疗经验和药物开发实力,基于Replicate的自复制RNA(srRNA)平台,共同开发针对肥胖、2型糖尿病等代谢疾病的新型候选疗法。根据协议,Replicate 将有资格从诺和诺德获得高达...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.